Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9232461 | 1.00 | PAM (0.47) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL5485532 | 1.00 | PAM (0.47) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL1248561 | 1.00 | PAM (0.47) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL17746757 | 1.00 | PAM (0.47) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL1248562 | 1.00 | PAM (0.47) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL97135 | 0.98 | PAM (0.48) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL22245646 | 0.94 | PAM (0.48) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL97322 | 0.94 | PAM (0.48) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL3795388 | 0.89 | SIGMAR1 (0.50) | PAMHDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL2399949 | 0.85 | PAM (0.52) | PAMTRPA1ALDH1A1LMNAALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | disclosed |
| US-20240390246-A1 | IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS | FIRMENICH SA (CH) | 2024-11-28 | — | — | US | disclosed |
| US-20240301319-A1 | PERFUMING COMPOSITIONS | FIRMNICH SA (CH) | 2024-09-12 | — | — | US | disclosed |
| US-12018226-B2 | Perfuming compositions | FIRMENICH SA (CH) | 2024-06-25 | — | — | US | disclosed |
| US-20230151305-A1 | FRAGRANCE COMPOSITION | SA, GIVAUDAN (CH) | 2023-05-18 | — | — | US | disclosed |
| US-11427783-B2 | Perfuming compositions | FIRMENICH SA (CH) | 2022-08-30 | — | — | US | disclosed |
| US-10806683-B2 | Encapsulated perfume compositions | GIVAUDAN SA (CH) | 2020-10-20 | — | — | US | disclosed |
| US-20200325415-A1 | PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2020-10-15 | — | — | US | disclosed |
| US-10722857-B2 | Encapsulated perfume compositions | GIVAUDAN S.A. (CH) | 2020-07-28 | — | — | US | disclosed |
| US-10537868-B2 | Microcapsules | GIVAUDAN S.A. (CH) | 2020-01-21 | — | — | US | disclosed |
| WO-2016207179-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2016-12-29 | — | — | WO | disclosed |
| WO-2016207180-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2016-12-29 | — | — | WO | disclosed |
| EP-2875111-A1 | COMPOSITIONS COMPRISING LIPASE AND METHODS OF USE THEREOF | Novozymes A/S (DK) | 2015-05-27 | — | — | EP | disclosed |
| WO-2013171241-A9 | COMPOSITIONS COMPRISING LIPASE AND METHODS OF USE THEREOF | NOVOZYMES A/S (DK) | 2014-11-27 | — | — | WO | disclosed |
| WO-2013171241-A1 | COMPOSITIONS COMPRISING LIPASE AND METHODS OF USE THEREOF | NOVOZYMES A/S (DK) | 2013-11-21 | — | — | WO | disclosed |
| EP-2262885-A1 | TRIGGERED RELEASE SYSTEM | Novozymes A/S (DK) | 2010-12-22 | — | — | EP | disclosed |
| EP-2254982-A1 | DETERGENT COMPOSITION COMPRISING A TRIGGERED RELEASE SYSTEM | Unilever N.V. (NL) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009118329-A1 | TRIGGERED RELEASE SYSTEM | NOVOZYMES A/S (DK) | 2009-10-01 | — | — | WO | disclosed |
| WO-2009118349-A1 | DETERGENT COMPOSITION COMPRISING A TRIGGERED RELEASE SYSTEM | UNILEVER NV (NL) | 2009-10-01 | — | — | WO | disclosed |
| US-4791098-A | 2-methyl-3-(p-methylphenyl)propionitrile, preparation and use thereof as scent | BASF AKTIENGESELLSCHAFT (DE) | 1988-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | PAM 1647/4885HDAC1 1829/4885HDAC8 2245/4885 |
| US-20240390246-A1 | IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS | PHGDH, SORD, CTH | PAM 918/4885HDAC1 2593/4885HDAC8 2397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.